Analyst Report: Upgrade for access Monogram Orthopedics Develops Futuristic Joint Replacement Robots
Monogram Orthopedics is combining 3D printing and robotics for customized joint replacements. It could massively disrupt orthopedic surgery.
- Company: Monogram Orthopedics on DealMaker Securities 2022
- Security Type: Equity - Preferred
- Valuation: $155,000,000
- Min Investment: $500
- Platform: Dealmaker Securities
- Deadline: Nov 21, 2022
The Future is Here
If someone asked you what the two most capital-intensive industries are, what would you say?
To me, the answer is crystal clear: medical technology and robotics.
For medical technology companies, getting FDA approval is a very expensive (but completely necessary) undertaking, particularly if clinical trials are necessary. For robotics companies, product development and prototyping require major amounts of capital.
Monogram Orthopedics, a Texas-based startup, has managed to cost-effectively merge these two industries.
The company is developing a robot that is able to perform knee and hip replacements without any user-initiated movements. Monogram is hoping (in the next few years) to deliver the following three-step patient experience:
Step 1: A computerized tomography (CT) scan of a patient’s knee/hip is taken to develop a virtual “map” of the affected area.
Step 2: An artificial intelligence-powered 3D printer creates a patient-specific press-fit implant (cementless implants believed to show higher stability than cemented implants, which are used in 92% of knee-transplants now) that matches the exact anatomy of each individual patient.
Step 3: Using the data from the CT scan, a robotic arm makes a precise cut in the knee/hip and inserts the custom implant with a high degree of accuracy.
Higher precision and faster surgeries. That’s the name of the game with Monogram.
At first glance, this may seem too futuristic (and borderline impossible).
I’m here to tell you that Monogram has nearly done it. The company is conducting live surgical demonstrations of its robot for the orthopedic community and is gearing up for FDA submission.
Once the company’s robot is approved by the FDA, Monogram will launch its first-generation knee offering with generic implants. Once this has been successfully rolled out to hospitals, the company will release its second generation of implants: 3D-printed implants that closely match a patient’s anatomy and stand to disrupt this space in a major way.
Let’s break our analysis of Monogram into three parts:
- Why is this technology better than legacy competitors’?
- Does the team have the experience to commercialize this technology?
- What are the risks?
This article requires: Edge Pro
Full site access including KingsCrowd's qualitative analyst reports.
- Everything in Edge, plus
- Full access to detailed Analyst Reports (e.g. Top Deal, Deal to Watch, Neutral, and Underweight)
- Search and filter based on Analyst Reports
- In-depth risk ratings for every raise
- Startup Portfolio Tracking
- Company Search Table
- Founder Profiles
- Trending Companies
- Fundraising Analytics
- News and Crowdopedia
Company Search table full access, except for Analyst Reports.
Charts and trends of capital raised by platform, security type, industry, and more.
Unlimited Top Deal, Deal to Watch, Neutral, and Underweight reports.
Unlock "Analyst Report" filters in the Company Search table.